PMD
Income statement / Annual
Last year (2023), Psychemedics Corporation's total revenue was $22.10 M,
a decrease of 12.45% from the previous year.
In 2023, Psychemedics Corporation's net income was -$4.15 M.
See Psychemedics Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$22.10 M
|
$25.24 M
|
$24.91 M
|
$21.36 M
|
$37.68 M
|
$42.67 M
|
$39.70 M
|
$38.98 M
|
$26.98 M
|
$29.20 M
|
| Cost of Revenue |
$13.69 M |
$15.95 M |
$14.65 M |
$16.47 M |
$21.23 M |
$22.06 M |
$19.88 M |
$17.53 M |
$14.26 M |
$14.07 M |
| Gross Profit |
$8.41 M |
$9.29 M |
$10.26 M |
$4.89 M |
$16.44 M |
$20.62 M |
$19.82 M |
$21.45 M |
$12.72 M |
$15.14 M |
| Gross Profit Ratio |
0.38 |
0.37 |
0.41 |
0.23 |
0.44 |
0.48 |
0.5 |
0.55 |
0.47 |
0.52 |
| Research and Development
Expenses |
$1.14 M
|
$1.33 M
|
$1.13 M
|
$1.28 M
|
$1.57 M
|
$1.55 M
|
$1.36 M
|
$1.42 M
|
$1.63 M
|
$1.35 M
|
| General & Administrative
Expenses |
$7.19 M
|
$5.86 M
|
$6.13 M
|
$6.10 M
|
$7.22 M
|
$6.43 M
|
$5.64 M
|
$4.97 M
|
$4.56 M
|
$4.47 M
|
| Selling & Marketing
Expenses |
$3.00 M
|
$3.19 M
|
$2.80 M
|
$3.58 M
|
$4.66 M
|
$5.03 M
|
$4.67 M
|
$4.96 M
|
$5.05 M
|
$4.63 M
|
| Selling, General &
Administrative Expenses |
$10.19 M
|
$9.05 M
|
$8.93 M
|
$9.67 M
|
$11.88 M
|
$11.46 M
|
$10.31 M
|
$9.93 M
|
$9.61 M
|
$9.10 M
|
| Other Expenses |
$0.00 |
$43,000.00 |
-$1.03 M |
-$140,000.00 |
$58,000.00 |
$43,000.00 |
$20,000.00 |
-$134,000.00 |
-$124,588.00 |
-$56,576.00 |
| Operating Expenses |
$11.33 M |
$10.37 M |
$10.06 M |
$10.95 M |
$13.45 M |
$13.01 M |
$11.67 M |
$11.34 M |
$11.25 M |
$10.45 M |
| Cost And Expenses |
$25.02 M |
$26.32 M |
$24.70 M |
$27.43 M |
$34.68 M |
$35.06 M |
$31.54 M |
$28.87 M |
$25.50 M |
$24.52 M |
| Interest Income |
$0.00 |
$0.00 |
$49,000.00 |
$75,000.00 |
$134,000.00 |
$149,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$49,000.00 |
$75,000.00 |
$59,000.00 |
$106,000.00 |
$0.00 |
$134,000.00 |
$124,588.00 |
$56,576.00 |
| Depreciation &
Amortization |
$2.67 M
|
$3.32 M
|
$3.69 M
|
$3.63 M
|
$2.91 M
|
$3.06 M
|
$2.81 M
|
$2.29 M
|
$1.73 M
|
$1.05 M
|
| EBITDA |
-$251,000.00
|
$2.23 M
|
$3.90 M
|
-$2.44 M
|
$5.91 M
|
$7.61 M
|
$10.96 M
|
$12.40 M
|
$2.75 M
|
$5.49 M
|
| EBITDA Ratio |
-0.01 |
-0.04 |
0.01 |
-0.28 |
0.08 |
0.18 |
0.21 |
0.26 |
0.05 |
0.16 |
| Operating Income Ratio
|
-0.13
|
-0.04
|
-0.14
|
-0.28
|
0
|
0.18
|
0.21
|
0.26
|
0.05
|
0.16
|
| Total Other
Income/Expenses Net |
-$517,000.00
|
$43,000.00
|
-$1.03 M
|
-$140,000.00
|
$58,000.00
|
$43,000.00
|
$20,000.00
|
-$134,000.00
|
-$124,000.00
|
-$57,000.00
|
| Income Before Tax |
-$3.44 M |
-$1.04 M |
-$821,000.00 |
-$6.21 M |
$3.06 M |
$7.65 M |
$8.18 M |
$9.98 M |
$1.35 M |
$4.63 M |
| Income Before Tax Ratio
|
-0.16
|
-0.04
|
-0.03
|
-0.29
|
0.08
|
0.18
|
0.21
|
0.26
|
0.05
|
0.16
|
| Income Tax Expense |
$716,000.00 |
$44,000.00 |
-$156,000.00 |
-$2.35 M |
$1.51 M |
$3.07 M |
$2.06 M |
$3.30 M |
-$164,388.00 |
$1.43 M |
| Net Income |
-$4.15 M |
-$1.08 M |
-$665,000.00 |
-$3.86 M |
$1.54 M |
$4.58 M |
$6.12 M |
$6.68 M |
$1.51 M |
$3.21 M |
| Net Income Ratio |
-0.19 |
-0.04 |
-0.03 |
-0.18 |
0.04 |
0.11 |
0.15 |
0.17 |
0.06 |
0.11 |
| EPS |
-0.72 |
-0.19 |
-0.12 |
-0.7 |
0.28 |
0.83 |
1.11 |
1.23 |
0.28 |
0.6 |
| EPS Diluted |
-0.72 |
-0.19 |
-0.12 |
-0.7 |
0.28 |
0.83 |
1.1 |
1.22 |
0.28 |
0.6 |
| Weighted Average Shares
Out |
$5.74 M
|
$5.63 M
|
$5.55 M
|
$5.52 M
|
$5.51 M
|
$5.51 M
|
$5.49 M
|
$5.45 M
|
$5.41 M
|
$5.36 M
|
| Weighted Average Shares
Out Diluted |
$5.74 M
|
$5.63 M
|
$5.55 M
|
$5.52 M
|
$5.53 M
|
$5.52 M
|
$5.56 M
|
$5.48 M
|
$5.41 M
|
$5.38 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
